GlobalData on MSN3d
Neuromod secures €10m to expand tinnitus treatment device’s availability
Irish medical device company Neuromod Devices has received €10m ($10.8m) in equity financing to broaden the reach of Lenire, ...
Neuromod raises €10m to continue expansion of tinnitus treatment device in US and European markets
Irish medtech group Neuromod Devices has raised €10 million equity financing to expand the availability of its tinnitus ...
Silicon Republic2d
Medtech Neuromod raises €10.5m and plans to make 40 new hires
Dublin-based Neuromod has raised €10.5m and plans to further fuel Lenire's commercialisation in Europe and reach US veterans.
Neuromod Closes €10 Million Financing to Accelerate Commercialisation
Neuromod Devices Ltd. (Neuromod), an Irish medical device company specialising in tinnitus, has successfully closed a €10 ...
MassDevice3d
Neuromod raises $10.9M to support neuromod for tinnitus
Neuromod Devices announced today that it closed an equity financing round worth proceeds of about $10.9 million (€10 million) ...
Irish Examiner on MSN3d
Irish med device expands its tinnitus treatment for US military vets
Neuromod has closed a €10m round of equity financing as it looks to expand the availability of its tinnitus treatment device ...
Independent.ie on MSN2d
‘We’re very much an Irish story all the way’ – Neuromod raises €10m to expand its tinnitus treatment
Irish medtech company Neuromod has raised €10m in equity financing to expand the production of Lenire – a device that helps ...
Morningstar3d
Neuromod Closes €10 Million Financing to Accelerate Commercialisation
Neuromod has raised €10 million of equity in an expansion of its Series B fundraisings. The financing was oversubscribed and was led by existing investors Fountain Healthcare Partners and ...
MassDevice3d
Sooma wins FDA IDE for neuromod tech that treats depression
Sooma announced that it received FDA investigational device exemption (IDE) for its transcranial direct current stimulation ...